← All organizations
Highest phase reached
Phase 3
First clinical trial
Nov 1, 2005Last known activity
Sep 25, 2024
Timeline
1940s
- Jun 1, 1943
SEPPIC, Paris— Founded
Drugs by trial phase (5 distinct, 8 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (8)
- NCT06571409Lead sponsorN/ASep 25, 2024
- NCT05799651CollaboratorPhase 1Apr 28, 2023
- NCT05209009CollaboratorPhase 2Aug 24, 2022
- NCT05226702CollaboratorPhase 1/Phase 2Jul 22, 2022
- NCT06037291Lead sponsorN/AOct 15, 2021
- NCT04702178CollaboratorPhase 1Feb 10, 2021
- NCT01767922CollaboratorPhase 3Sep 1, 2008
- NCT00730782CollaboratorPhase 1Nov 1, 2005
Details
- Founded
- Paris, FR Jun 1, 1943
- Last known activity
- Sep 25, 2024